Donate to Cutaneous Lymphoma Research, Patient Care and Education
Most common among men, over 30,000 people will be diagnosed with cutaneous lymphoma in the United State this year. Cutaneous lymphoma is cancer that manifests in the skin cells and impairs the body’s immune system. Cutaneous lymphoma is diagnosed as either T-cell lymphoma or B-cell lymphoma. Nearly half of all cutaneous lymphomas diagnosed at T-cell lymphomas and present symptoms of patchy, scaly red lesions on the skin. Some will experience raised tumors that appear to be bumps on the skin. In B-cell lymphoma, symptoms also appear as red rashes on the upper body and is often associated with lyme disease. Thanks to your generous donations, board-certified physicians at Northwestern Medicine continue to advance research and clinical trials to develop new prevention, diagnostic and treatment options for patients afflicted with cutaneous lymphoma.
Age, gender, a weakened immune system and certain infections are all risk factor associated with cutaneous lymphoma. Multiple forms of itchy, scaly and red lesion are symptoms of cutaneous lymphoma. Weight loss, fever and sweating can also be attributed to cutaneous lymphoma. While each of these symptoms alone may not result in a diagnosis of cutaneous lymphoma, it is critical that a full physical exam is performed by your physician. In addition to a medical history and physical exam, physicians may also order various forms of biopsies, spinal taps and a host of blood tests as well as imaging tests (scans).
Cutaneous Lymphoma Research, Patient Care and Education Donation
With your donations, teams of specialists at Northwestern Medicine are able to develop diagnosis and recommend custom treatment options based on the type and severity of cutaneous lymphoma present. These treatment options can include surgery, radiation, UV light therapy as well as topical skin therapies that may consist of salves, ointments and injections. Will not you consider a gift to Northwestern Medicine to help develop treatment options for those afflicted with various forms of cutaneous lymphoma?